1024P Initial clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb, administered as single agent and in combination with pembrolizumab in patients with advanced solid tumors. - Champiat, S.; Lebbe, C.; Baurain, J-F.; Italiano, A.; Sakkal, M.; Spring-Giusti, C.; Stojkowitz, N.; Brandely, M.; Sadoun, A.; Ropenga, A.; Semmrich, M.; McAllister, A.; et al. (Annals of Oncology, 2024)